ATE336998T1 - Antioxidative zusammensetzungen für haustiere - Google Patents

Antioxidative zusammensetzungen für haustiere

Info

Publication number
ATE336998T1
ATE336998T1 AT00901737T AT00901737T ATE336998T1 AT E336998 T1 ATE336998 T1 AT E336998T1 AT 00901737 T AT00901737 T AT 00901737T AT 00901737 T AT00901737 T AT 00901737T AT E336998 T1 ATE336998 T1 AT E336998T1
Authority
AT
Austria
Prior art keywords
dog
cat
vitamin
oxidative stress
pets
Prior art date
Application number
AT00901737T
Other languages
English (en)
Inventor
Jean E Harper
Original Assignee
Mars Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902051.3A external-priority patent/GB9902051D0/en
Priority claimed from GBGB9928549.6A external-priority patent/GB9928549D0/en
Application filed by Mars Uk Ltd filed Critical Mars Uk Ltd
Application granted granted Critical
Publication of ATE336998T1 publication Critical patent/ATE336998T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
AT00901737T 1999-01-29 2000-01-31 Antioxidative zusammensetzungen für haustiere ATE336998T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902051.3A GB9902051D0 (en) 1999-01-29 1999-01-29 Compositions and methods
GBGB9928549.6A GB9928549D0 (en) 1999-12-02 1999-12-02 Compositions and methods

Publications (1)

Publication Number Publication Date
ATE336998T1 true ATE336998T1 (de) 2006-09-15

Family

ID=26315062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901737T ATE336998T1 (de) 1999-01-29 2000-01-31 Antioxidative zusammensetzungen für haustiere

Country Status (14)

Country Link
EP (1) EP1146870B1 (de)
JP (1) JP4966450B2 (de)
CN (1) CN1342073A (de)
AT (1) ATE336998T1 (de)
AU (1) AU766335C (de)
BR (1) BR0007862A (de)
CA (1) CA2360680C (de)
DE (1) DE60030253T2 (de)
GB (1) GB2366179B (de)
HU (1) HUP0200075A3 (de)
MX (1) MXPA01007661A (de)
NZ (2) NZ527924A (de)
PL (1) PL350187A1 (de)
WO (1) WO2000044375A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2367489B (en) * 2000-07-31 2005-02-09 Mars Inc Use of antioxidants
EP1179984B2 (de) * 1999-05-27 2011-10-05 The Iams Company Verfahren zur herstellung von produkt zur erhöhung der immunantwort in haustieren mit verwendung einer kombination von antioxidantien
MXPA02002195A (es) * 1999-09-09 2002-09-18 Nestle Sa Mejoramiento del estado de mascotas viejas.
US6996807B1 (en) * 2000-02-01 2006-02-07 Isogon Corporation Consolidation and reduction of usage data
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
CN1853496B (zh) * 2000-10-31 2011-11-02 高露洁-棕榄公司 组合物和方法
AU2007216796B2 (en) * 2000-10-31 2011-06-09 Colgate-Palmolive Company Composition and method
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
US8592479B2 (en) * 2000-10-31 2013-11-26 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
GB0119052D0 (en) * 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
CA2456743A1 (en) 2001-08-21 2003-02-27 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20040116514A1 (en) * 2002-01-31 2004-06-17 Hoyoku Nishino Compositions for preventing human cancer and method of preventing human cancer
GB0202258D0 (en) * 2002-01-31 2002-03-20 Dodson & Horrell Ltd Annimal feed supplement
ES2355890T3 (es) † 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
GB0218932D0 (en) * 2002-08-14 2002-09-25 Zoolife Internat Ltd Composition for dietary enrichment
CA2510729C (en) * 2002-12-20 2011-11-29 Mars Uk Limited Foodstuff profile for cats
EP1589964B1 (de) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Verbindungen mit proliferationshemmenden eigenschaften
DK1641351T3 (da) * 2003-07-03 2014-08-25 Hills Pet Nutrition Inc Sammensætninger og fremgangsmåder til at formindske aldersrelateret forringelse af mental aktivitet hos familiedyr
JP2007525201A (ja) 2003-07-07 2007-09-06 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルにおいて改良された酸化的状態を得るための組成物
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
AU2005232392B2 (en) * 2004-04-16 2011-01-06 Société des Produits Nestlé S.A. Method and compositions for reducing oxidative stress in an animal
JP4814568B2 (ja) * 2004-09-02 2011-11-16 コスモ石油株式会社 免疫機能向上剤
ES2459366T3 (es) 2004-09-02 2014-05-09 Cosmo Oil Co., Ltd. Agentes mejoradores de la función constitutiva
RU2433819C2 (ru) 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
CA2592389C (en) 2004-12-29 2013-05-14 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
EP1844006A2 (de) * 2005-01-05 2007-10-17 Magd Ahmed Kotb Abdalla Taurinsynthese-herstellung und -verwendung als medizin
AU2006236345B2 (en) 2005-04-19 2011-03-31 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
CN101287460B (zh) 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
EP1978821B2 (de) † 2005-12-29 2019-02-06 Hill's Pet Nutrition, Inc. Verfahren zum modifizieren der darmflora bei tieren
CA2644848C (en) * 2006-04-04 2013-10-01 Hill's Pet Nutrition, Inc. Compositions and methods for enhancing the antioxidant status of animals
WO2008099469A1 (ja) * 2007-02-14 2008-08-21 Tohoku University 赤血球の脂質過酸化を抑制するための組成物および方法
BRPI0807789A2 (pt) * 2007-02-22 2014-06-24 Hill S Pet Nutriton Inc Composição de ração para animal de estimação, ração para animal de estimação, e, uso de uma composição
IL184575A0 (en) * 2007-07-12 2008-01-20 Lycored Ltd Synergistic combinations for treating hypertension
CN102170792A (zh) * 2008-07-18 2011-08-31 希尔氏宠物营养品公司 提高老龄动物生活质量的方法
BRPI0923454A2 (pt) * 2008-12-16 2015-07-28 Hills Pet Nutrition Inc "métodos para intensificar uma capacidade de um animal de estimação resistir ou combater uma infecção viral e para tratar uma infecção viral em um animal de estimação.
WO2011059474A1 (en) * 2009-10-30 2011-05-19 Nestec S.A. Methods for maintaining eye health and ameliorating opthalmic maladies in canines
EP2531047B1 (de) 2010-02-05 2024-11-13 Phosphagenics Limited Träger mit einem nichtneutralisierten tocopherylphosphat
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
DE102011052687A1 (de) 2011-08-12 2013-02-14 Lohmann Animal Health Gmbh Verwendung von Antioxidantien
MY158177A (en) * 2014-12-04 2016-09-06 Univ Putra Malaysia Antioxidant and/or antimicrobial composition based on palm oil
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
IL267006B2 (en) 2016-12-21 2024-11-01 Phosphagenics Ltd Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
GB201804698D0 (en) * 2018-03-23 2018-05-09 Mars Inc Reduced methionine diet for dogs
CA3164484A1 (en) * 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate in canines using tomato pomace and methods of identifying canines at risk of such conditions
US12604918B2 (en) 2020-01-21 2026-04-21 Lintbells Limited Synergistic compositions
US11690878B2 (en) 2020-01-21 2023-07-04 Lintbells Limited Synergistic compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
GB2042337A (en) * 1979-02-28 1980-09-24 Fox E Pharmaceutical composition for arthritic conditions
GB2185673B (en) * 1986-01-08 1990-03-21 Mitsubishi Gas Chemical Co Palm leaf fodder
JPS62195254A (ja) * 1986-02-19 1987-08-28 Mitsubishi Gas Chem Co Inc 飼料
US5141755A (en) * 1991-05-29 1992-08-25 Weisman Eric H Reduced animal product pet food composition
JPH0779712A (ja) * 1993-09-17 1995-03-28 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
JP2696485B2 (ja) * 1994-07-07 1998-01-14 日本物産株式会社 多量ミネラル成分含有魚貝藻類エキスの抽出方法
AT506U1 (de) * 1994-11-22 1995-12-27 Erber Erich Kg Futtermittel- bzw. trinkwasserzusatz zur verbesserung der stressresistenz und der immunität von nutztieren
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur
EP0834262A4 (de) * 1996-04-10 1999-03-24 Nichimo Kk Stoff mit einer gesundheitsverbessernden komponente und verfahren zu seiner herstellung
ZA965149B (en) * 1996-06-18 1997-01-23 Henry John Davis Vitamin and nutrient supplement compositions
JPH10175866A (ja) * 1996-12-18 1998-06-30 Showa Denko Kk 動物用ストレス反応緩和剤及びストレス反応の緩和方法
AU770392B2 (en) * 1998-07-07 2004-02-19 Coastside Bio Resources Companion animal therapeutic treat

Also Published As

Publication number Publication date
PL350187A1 (en) 2002-11-18
JP4966450B2 (ja) 2012-07-04
DE60030253T2 (de) 2007-07-19
WO2000044375A1 (en) 2000-08-03
MXPA01007661A (es) 2002-07-02
GB0118809D0 (en) 2001-09-26
JP2002535364A (ja) 2002-10-22
BR0007862A (pt) 2001-10-23
DE60030253D1 (de) 2006-10-05
HUP0200075A3 (en) 2005-05-30
AU766335C (en) 2004-06-03
CA2360680A1 (en) 2000-08-03
CN1342073A (zh) 2002-03-27
EP1146870A1 (de) 2001-10-24
GB2366179A (en) 2002-03-06
CA2360680C (en) 2010-04-13
AU766335B2 (en) 2003-10-16
HUP0200075A2 (hu) 2002-05-29
NZ527924A (en) 2005-01-28
AU2304200A (en) 2000-08-18
GB2366179B (en) 2003-04-16
EP1146870B1 (de) 2006-08-23
NZ513131A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
ATE336998T1 (de) Antioxidative zusammensetzungen für haustiere
NO20004911D0 (no) Antitumormiddel
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
WO2005003766A3 (en) Methods of regulating metabolism and mitochondrial function
BR0013879A (pt) Melhoria da condição de saúde de animais de estimação de idade avançada
WO2004017920A3 (en) Novel biphenyl and biphenyl-like cannabinoids
EP1262177A3 (de) Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
DE60231439D1 (de) Mitotische kinesinhemmer
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ATE372341T1 (de) Inhibitoren von mitotischem kinesin
DE60329990D1 (de) Mitotische kinesin-hemmer
ATE293691T1 (de) Myostatin genpromoter und inhibierung dessen aktivierung
DE60135647D1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
Kim et al. Inhibition of UVB‐Induced Skin Damage by Exopolymers from Aureobasidium pullulans SM‐2001 in Hairless Mice
DE69722557D1 (de) Verwendung von Sericin als Antioxidantien und Tyrosinase-Inhibitoren
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
ATE306263T1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
GARSSEN et al. The role of urocanic acid in UVB‐induced suppression of immunity to Trichinella spiralis infection in the rat
MXPA03011270A (es) Uso de antagonistas rank para tratar cancer.
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
SE0301883D0 (sv) New use II
DK1043028T3 (da) Phytase til forebyggelse eller behandling af mastitis
DE602004016292D1 (de) Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
EP1663280A4 (de) Verfahren zur verbesserung der hämatopoiese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties